1. Home
  2. YMAB vs EBTC Comparison

YMAB vs EBTC Comparison

Compare YMAB & EBTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • YMAB
  • EBTC
  • Stock Information
  • Founded
  • YMAB 2015
  • EBTC 1989
  • Country
  • YMAB United States
  • EBTC United States
  • Employees
  • YMAB N/A
  • EBTC N/A
  • Industry
  • YMAB Biotechnology: Pharmaceutical Preparations
  • EBTC Major Banks
  • Sector
  • YMAB Health Care
  • EBTC Finance
  • Exchange
  • YMAB Nasdaq
  • EBTC Nasdaq
  • Market Cap
  • YMAB 482.4M
  • EBTC 455.5M
  • IPO Year
  • YMAB 2018
  • EBTC 2005
  • Fundamental
  • Price
  • YMAB $9.38
  • EBTC $42.37
  • Analyst Decision
  • YMAB Strong Buy
  • EBTC
  • Analyst Count
  • YMAB 10
  • EBTC 0
  • Target Price
  • YMAB $21.00
  • EBTC N/A
  • AVG Volume (30 Days)
  • YMAB 243.1K
  • EBTC 50.1K
  • Earning Date
  • YMAB 11-08-2024
  • EBTC 01-23-2025
  • Dividend Yield
  • YMAB N/A
  • EBTC 2.21%
  • EPS Growth
  • YMAB N/A
  • EBTC N/A
  • EPS
  • YMAB N/A
  • EBTC 2.91
  • Revenue
  • YMAB $84,553,000.00
  • EBTC $164,115,000.00
  • Revenue This Year
  • YMAB $6.46
  • EBTC N/A
  • Revenue Next Year
  • YMAB $20.68
  • EBTC N/A
  • P/E Ratio
  • YMAB N/A
  • EBTC $14.94
  • Revenue Growth
  • YMAB N/A
  • EBTC N/A
  • 52 Week Low
  • YMAB $6.09
  • EBTC $22.60
  • 52 Week High
  • YMAB $20.90
  • EBTC $44.08
  • Technical
  • Relative Strength Index (RSI)
  • YMAB 32.17
  • EBTC 68.09
  • Support Level
  • YMAB $9.31
  • EBTC $42.13
  • Resistance Level
  • YMAB $11.10
  • EBTC $43.48
  • Average True Range (ATR)
  • YMAB 0.72
  • EBTC 1.24
  • MACD
  • YMAB -0.00
  • EBTC 0.30
  • Stochastic Oscillator
  • YMAB 3.87
  • EBTC 83.61

About YMAB Y-mAbs Therapeutics Inc.

Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. DANYELZA, is the first FDA-approved product of the company which is a recombinant humanized immunoglobulin G, subtype 1k, or IgG1k, monoclonal antibody or mAb that targets ganglioside GD2, which is expressed in various neuroectoderm-derived tumors and sarcomas.

About EBTC Enterprise Bancorp Inc

Enterprise Bancorp Inc is a holding company engaged in the business of gathering deposits from the general public and investing in loans and investment securities. Through the Bank and its subsidiaries, the company offers a range of commercial, residential, and consumer loan products, deposit products, and cash management services, as well as wealth management and wealth services.

Share on Social Networks: